You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

ZURNAI (AUTOINJECTOR) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Zurnai (autoinjector) patents expire, and what generic alternatives are available?

Zurnai (autoinjector) is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are twenty-one patents protecting this drug.

This drug has sixty-eight patent family members in fourteen countries.

The generic ingredient in ZURNAI (AUTOINJECTOR) is nalmefene hydrochloride. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nalmefene hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zurnai (autoinjector)

A generic version of ZURNAI (AUTOINJECTOR) was approved as nalmefene hydrochloride by PURDUE PHARMA LP on February 8th, 2022.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ZURNAI (AUTOINJECTOR)?
  • What are the global sales for ZURNAI (AUTOINJECTOR)?
  • What is Average Wholesale Price for ZURNAI (AUTOINJECTOR)?
Summary for ZURNAI (AUTOINJECTOR)
Drug patent expirations by year for ZURNAI (AUTOINJECTOR)

US Patents and Regulatory Information for ZURNAI (AUTOINJECTOR)

ZURNAI (AUTOINJECTOR) is protected by twenty-one US patents.

Patents protecting ZURNAI (AUTOINJECTOR)

Injection device with cammed RAM assembly
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Needle assisted jet injection device having reduced trigger force
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Prefilled syringe injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Needle assisted injection device having reduced trigger force
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Injection device with cammed ram assembly
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Injection device with cammed ram assembly
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Syringe shock absorber for use in an injection device
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Prefilled syringe injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATING OPIOID OVERDOSE

Prefilled syringe jet injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Injection device with cammed ram assembly
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Prefilled syringe jet injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Prefilled syringe jet injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Injection device with cammed ram assembly
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Needle assisted jet injection device having reduced trigger force
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Injection device with cammed ram assembly
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Prefilled syringe jet injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Prefilled syringe jet injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purdue Pharma Lp ZURNAI (AUTOINJECTOR) nalmefene hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 218590-001 Aug 7, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Purdue Pharma Lp ZURNAI (AUTOINJECTOR) nalmefene hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 218590-001 Aug 7, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Purdue Pharma Lp ZURNAI (AUTOINJECTOR) nalmefene hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 218590-001 Aug 7, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ZURNAI (AUTOINJECTOR)

See the table below for patents covering ZURNAI (AUTOINJECTOR) around the world.

Country Patent Number Title Estimated Expiration
South Korea 20070117543 PREFILLED NEEDLE ASSISTED JET INJECTOR ⤷  Sign Up
European Patent Office 2833944 ADMINISTRATION PAR INJECTION PAR JET ASSISTÉE PAR UNE AIGUILLE DE COMPOSITIONS DE TESTOSTÉRONE (NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS) ⤷  Sign Up
Denmark 3659647 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.